95253 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings
HETEROCYCLIC AMIDES AND METHODS OF USING THE SAME
#302PARP7 INHIBITORS
#303Heterocyclic Carboxylate Compounds as Glycolate Oxidase Inhibitors
#304COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY APPARATUS
#305TRICYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#306ANTIVIRAL COMPOUNDS
#307SOLID STATE FORMS OF AN FGFR INHIBITOR
#308PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS
#309Process for Manufacturing Pibrentasvir Active Drug Substance
#310NOVEL COMPOUND FOR IMPROVING SLEEP OR USE THEREOF
#311SMALL MOLECULE INHIBITORS OF PR3 AND HNE AND USES THEREOF
#312Glucose and Lipid Metabolism Regulating Agents, Pharmaceutical Compositions Comprising the Same, and Treatment Methods
#313PESTICIDALLY ACTIVE PYRIDAZINONE COMPOUNDS
#314COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF
#315HETEROCYCLIC SUBSTITUTED 1,3,4-THIADIAZOLE AND PYRIDAZINE COMPOUNDS AND METHODS OF USING THE SAME
#316SUBSTITUTED N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS
#317PYRIDAZINONES AS PARP7 INHIBITORS
#318COMPOUNDS, COMPOSITIONS, AND METHODS
#3191,4-DIHETEROCYCLIC SUBSTITUTED AROMATIC RING OR AROMATIC HETEROCYCLIC COMPOUND AND USE THEREOF
#320KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE
#321EGFR INHIBITORS AND METHODS OF USE THEREOF
#322TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS
#323COLIBACTIN DERIVATIVES AND METHODS OF TREATING, AMELIORATING, AND/OR PREVENTING CANCER
#324N-(4-aminocyclohexyl)pyrimidine-4-carboxamide derivatives as CD38 inhibitors
#325STING AGONIST COMPOUNDS AND METHODS OF USE
#326PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS
#327THERAPEUTIC COCRYSTALS OF 3-{[5-(AZETIDINE-1-YLCARBONYL)PYRAZIN-2-YL]OXY}-5-{[(1S)-1-METHYL-2-(METHOXY)ETHYL]OXY)-N-(5-METHYLPYRAZIN-2-YL)BENZAMIDE
#328NOVEL CAPSID ASSEMBLY INHIBITORS
#329BIFUNCTIONAL COMPOUNDS FOR DEGRADING ITK VIA UBIQUITIN PROTEOSOME PATHWAY
#330Pyrazolopyridine derivatives and uses thereof
#331AZETIDINYL PYRIMIDINES AND USES THEREOF
#332SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS
#333NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR
#3343,3-DIFLUOROALLYLAMINES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#335HETEROARYL-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS AS PESTICIDES
#336BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6
#337INHIBITORS OF RET
#338CYANO CYCLOBUTYL COMPOUNDS FOR CBL-B INHIBITION AND USES THEREOF
#339SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE
#340Disubstituted Pyrimidine Compounds for Ketohexokinase Inhibition
#341COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES
#342PYRAZOLE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE
#343SULFONYL-TRIAZOLES USEFUL AS COVALENT KINASE LIGANDS
#344AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS
#3454,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF
#346BIPYRROLINONE COMPOUND
#347HETEROARYL DERIVATIVE AND USE THEREOF
#348BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF
#349SRPK INHIBITORS
#350METALLODRUG THERAPEUTIC COMPOUNDS AND PRODRUGS OF METALLODRUG THERAPEUTIC COMPOUNDS
#351IMIDAZOLE-CONTAINING INHIBITORS OF ALK2 KINASE
#352NUCLEAR TRANSPORT MODULATORS AND USES THEREOF
#353SMALL MOLECULE CYCLIN DEPENDENT KINASE 4/6 (CDK4/6) AND IKZF2 (HELIOS) DEGRADERS AND METHODS OF USE THEREOF
#354SOLID FORM OF RHO-ASSOCIATED PROTEIN KINASE INHIBITOR OR SOLVATE THEREOF, PREPARATION METHOD AND USE THEREOF
#355Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use Thereof
#356QUATERNARY AMMONIUM CATION SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
#357SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER
#358INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#359SELECTIVE INHIBITORS OF ROCK1 AND ROCK2 PROTEIN KINASES AND THEIR USES THEREOF
#360PIKfyve Inhibitors
#361QUINOXALINE DERIVATIVES AND USES THEREOF
#362COMPOUNDS AND METHODS FOR MODULATING SPLICING
#363BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS
#364Compounds for the Treatment of Pain, in Particular, Neuropathic Pain, and/or Other Diseases or Disorders that are Associated with AT2R and/or AT2R Mediated Signaling
#365ROCK2 INHIBITORS AND USES THEREOF
#366RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
#367HETEROCYCLIC COMPOUNDS
#368BICYCLIC 1,4-DIAZEPANONES AND THERAPEUTIC USES THEREOF
#369ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS
#370ARYLQUINAZOLINES
#371ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES
#372GLS1 INHIBITORS FOR TREATING DISEASE
#373THYROID HORMONE RECEPTOR AGONISTS AND USES THEREOF
#374PROCESS FOR POLYAMIDE SYNTHESIS
#375TRANSCRIPTIONAL ENHANCED ASSOCIATED DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF
#376COMPLEMENT INHIBITION
#377PYRAZOLE AND IMIDAZOLE COMPOUNDS FOR INHIBITION OF IL-17 AND RORGAMMA
#378ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE-1 (ENPP1) INHIBITORS AND USES THEREOF
#3791,5-DISUBSTITUTED 1,2,3-TRIAZOLES ARE INHIBITORS OF RAC/CDC42 GTPASES
#380Prodigiosin Analogs And Methods Of Use
#381ARYL HYDROCARBON RECEPTOR MODULATORS AND THEIR USE IN THE TREATMENT OF DISEASES AND DISORDERS
#382INDOLINE COMPOUNDS FOR INHIBITING KIF18A
#383PYRIDAZINONE OR PYRIDINONE COMPOUNDS, PREPARATION METHODS AND USES THEREOF
#384ANALOGS FOR THE TREATMENT OF DISEASE
#3854-PHENYL-INDOLE DERIVATIVES AND RELATED USES
#386PHOTOSENSITIVE POLYAMIC ACID AND DIAZIRINE COMPOSITIONS
#387Hydroquinazoline derivatives for the treatment of a disease or disorder
#388METHYL-SUBSTITUTED PYRIDINE AND PYRIDAZINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE
#389SMALL MOLECULE INHIBITION OF DEUBIQUITINATING ENZYME JOSEPHIN DOMAIN CONTAINING 1 (JOSD1) AS A TARGETED THERAPY FOR LEUKEMIAS WITH MUTANT JANUS KINASE 2 (JAK2)
#390COMPOSITION FOR OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE
#391PYRIMIDINE OR PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN PHARMACY
#392TRIAZINE DERIVATIVES FOR THE TREATMENT OF TUMOURS AND NEURODEGENERATIVE DISORDERS
#393AHR INHIBITOR, USE THEREOF, AND PREPARATION METHOD THEREFOR
#394SUBSTITUTED HETEROBICYCLIC DERIVATIVES AS NEGATIVE ALLOSTERIC MODULATORS OF MGLU7 RECEPTOR
#395PYRIMIDINE BASED RAS MODULATORS AND USES THEREOF
#396AMIDE AND ETHER SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF
#397HOST MATERIALS FOR ELECTROLUMINESCENT DEVICES
#398LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND
#399ELECTROLUMINESCENT DEVICES
#400COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT
#401SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE
#402PYRAZOLYL DERIVATIVES AS INHIBITORS OF THE KRAS MUTANT PROTEIN
#403COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE
#404Compounds useful for treating gastrointestinal tract disorders
#405POTASSIUM CHANNEL MODULATORS
#406Method For Controlling Diamide Resistant Pests and Compounds Therefor
#407SMALL MOLECULE INHIBITOR AGAINST NASOPHARYNGEAL CARCINOMA, PREPARATION METHOD AND APPLICATION THEREOF
#408LIGHT-EMITTING DEVICE AND DISPLAY DEVICE
#409PREPARATION OF SUBSTITUTED 1,2-DIAMINOHETEROCYCLIC COMPOUND DERIVATIVES AND THEIR USE AS PHARMACEUTICAL AGENTS
#410TETRAHYDROPYRROLOCYCLIC COMPOUND AND APPLICATION THEREOF
#411Quinazoline Compounds and Uses
#412Novel imidazole derivatives having protein kinase inhibitory activity and uses thereof
#413ADAMTS INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF
#414HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS
#415PYRIDAZINONE COMPOUND AS PARP7 INHIBITOR
#416RIP1 MODULATORS INCLUDING AZETIDINE CYCLIC UREAS, PREPARATIONS, AND USES THEREOF
#417THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
#418PESTICIDALLY ACTIVE DIAZINE-AMIDE COMPOUNDS
#419PYRAZOLYL-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS
#420Modulators of RAS GTPase
#421NOVEL BENZIMIDAZOLE DERIVATIVE
#422COMPOSITION, LIGHT-EMITTING DEVICE INCLUDING THE COMPOSITION, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE
#423SUBSTITUTED HETEROCYCLIC COMPOUNDS
#424POLO LIKE KINASE 4 INHIBITORS
#425INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF
#426INDAZOLE YL BENZIMIDAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND USE THEREOF
#427COMPOUNDS HAVING N-ARYLPYRIMIDIN-2-AMINE DERIVATIVES AS THERAPEUTIC AGENTS
#428HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#429MATERIALS FOR ORGANIC LIGHT EMITTING DEVICES
#430BENZIMIDAZOYL GLP-1 RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE
#431SYNTHESIS OF NOVEL CEREBLON E3 LIGASE LIGANDS, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#432COMPOSITION, LIGHT-EMITTING DEVICE, AND ELECTRONIC APPARATUS INCLUDING THE SAME
#433HETEROCYCLIC COMPOUNDS AND USES THEREOF
#434MLKL BINDING OR DEGRADING COMPOUND AND PHARMACEUTICAL USE THEREOF
#435HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE AND COMPOSITION FOR ORGANIC MATERIAL LAYER COMPRISING THE SAME
#436TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE
#437BENZAMIDE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER CONTAINING SAME AS ACTIVE INGREDIENT
#438HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF
#439Nitrogen-containing compound, and organic electroluminescent device and electronic apparatus thereof
#440TRIAZOLE DERIVATIVES WITH ANTIFUNGAL ACTIVITY
#441EBNA1 Inhibitors and Methods Using Same
#442NITRIC OXIDE RELEASING PHOSPHODIESTERASE TYPE 5 INHIBITOR
#443Papain-like protease (PLpro) inhibitors
#444INDOLE COMPOUNDS AND METHODS OF USE
#4451H-PYRAZOLE DERIVATIVES AS SIGMA LIGANDS
#446SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF
#447PHTHALAZINONE DERIVATES AS NLRP3 INFLAMMASOME INHIBITORS
#448Phenanthroimidazole derivative, and preparation method therefor and application thereof
#449PIPERAZINE DERIVATIVES AND APPLICATION THEREOF
#450Triazole-substituted imidazo[1,2-a]pyrimidines as cGAS inhibitors
#451PCSK9 INHIBITORS AND METHODS OF USE THEREOF
#452INDIRUBIN COMPOUNDS AND METHODS THEREOF
#453INHIBITORS OF PLASMA KALLIKREIN
#454Heteroaryl Fluoroalkenes As DGK Inhibitors
#455PHARMACEUTICAL COMPOUND
#456INDOLINE DERIVATIVES AS DDRS INHIBITORS
#457RECEPTOR-INTERACTING PROTEIN 1 INHIBITORS, PREPARATIONS, AND USES THEREOF
#458SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
#459MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE
#460ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES
#461Pyrimidine or Pyridine Compounds, Preparation Method Therefor and Pharmaceutical Uses Thereof
#462HETEROARYL ALKYLENE SUBSTITUTED 2-OXOQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS
#463TRIAZINE DERIVATIVE AS REVERSIBLE AND IRREVERSIBLE COVALENT INHIBITORS OF PI3K
#464ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES
#465JAK1 SELECTIVE INHIBITORS
#466MTA-Cooperative PRMT5 Inhibitors
#467ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE
#468FLUORESCENT COMPOUND FOR IMMUNOHISCHEMISTRY AND DIAGNOSIS COMPOSITION FOR DETECTING BIOLOGICAL MATERIAL COMPRISING THE SAME
#469CTLA-4 SMALL MOLECULE DEGRADATION AGENT AND APPLICATION THEREOF
#470QUINAZOLINE-4(3H)-ONE DERIVATIVES AS NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2
#471NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2
#472COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2
#473BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY
#474SMALL MOLECULES FOR THE TREATMENT OF KINASE-RELATED DISEASES
#475Chiral TACN/NOTA compounds/derivatives with and without metals for application
#476HETEROCYCLIC COMPOUNDS
#477COMPOUND OR TAUTOMER THEREOF, COMPOSITION, LAMINATE, OPTICAL FILM, IMAGE FORMING MATERIAL, AND METHOD FOR PRODUCING COMPOUND OR TAUTOMER THEREOF
#478KRAS INHIBITORS
#479ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS
#480Inhibitors of receptor interacting protein kinase I for the treatment of disease
#481INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF
#482AMINOPYRIMIDINE COMPOUNDS AND METHODS OF THEIR USE
#483INHIBITORS OF LRRK2 KINASE
#484INDOLINE DERIVATIVES AS DDR1 AND DDR2 INHIBITORS
#485PYRIDAZINONES AS PARP7 INHIBITORS
#486ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#487Tropomyosin-related kinase (trk) inhibitors
#488ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES
#489Polycyclic Compound for Inhibiting RNA Helicase DHX33, and Application of Compound
#490Triazine derivatives and methods of use thereof
#491TYK2 INHIBITOR COMPOUND CONTAINING BICYCLIC RING
#492HETEROAROYL AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
#493CDK2 INHIBITORS AND USES THEREOF
#494Small Molecule Compound
#495COMPOUND, PRODUCTION METHOD THEREFOR, COMPLEX, AND SHORT WAVELENGTH INFRARED FLUORESCENT AGENT
#496ORGANIC ELECTRIC ELEMENT USING COMPOUND FOR ORGANIC ELECTRIC ELEMENT, AND ELECTRONIC DEVICE THEREOF
#497NOVEL PYRIMIDINE DERIVATIVE SHOWING INHIBITION EFFECT ON GROWTH OF CANCER CELLS
#498Multi-aziridine compound
#499ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#500PYRAZOLE COMPOUNDS SUBSTITUTED WITH HETEROARYL AND PHARMACEUTICAL USE THEREOF
#501NLRX1 LIGANDS
#502LIGHT EMITTING ELEMENT AND NITROGEN CONTAINING COMPOUND FOR THE SAME
#503ORGANIC COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME
#504Pyrazolopyridine derivatives and uses thereof
#505BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF
#506PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY
#507METHODS AND COMPOUNDS FOR TREATING DISORDERS
#508Bipyrazole derivatives as JAK inhibitors
#509CARBOXAMIDE COMPOUNDS AND USES THEREOF
#510NOVEL COMPOUND AS PROTEIN KINASE INHIBITORS
#511PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY
#512Quaternary indazole glucocorticoid receptor antagonists
#513Light-emitting element, light-emitting device, electronic device, lighting device, and organic compound
#514NON-COVALENT DIMER CATION, SALT THEREOF, PREPARATION METHOD THEREOF, AND USE THEREOF AS ANTIOXIDANT
#515Cycloalkyl pyrimidines as ferroportin inhibitors
#516GLP-1 Receptor Agonists and Uses Thereof
#517COMPOUND AND LABELED BIOLOGICAL SUBSTANCE USING THE SAME
#518Benzimidazole Derivatives and Their Use As Inhibitors of ITK For The Treatment of Skin Disease
#519MATERIALS FOR ELECTRONIC DEVICES
#520PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS
#521TYK2 inhibitors and compositions and methods thereof
#522HETEROCYCLIC INHIBITORS OF PCSK9
#523Polo like kinase 4 inhibitors
#524COMPOUNDS USEFUL AS IMMUNOMODULATORS
#525IMMUNOMODULATORY ANTIBODY-DRUG CONJUGATES
#526LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2
#527ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4
#528Substituted pyridine derivatives as SARM1 inhibitors
#529NEW CRYSTALLINE FORMS OF A KRAS G12C INHIBITOR COMPOUND
#530Beta-lactam derivatives for the treatment of diseases
#531PROTEASOME ACTIVITY ENHANCING COMPOUNDS
#532DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENT
#533Anti-viral compounds
#534DEBRIDING DRESSING FOR USE WITH NEGATIVE PRESSURE AND FLUID INSTILLATION
#535ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#536HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC MATERIAL LAYER
#537ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#538Substituted benzamides as intermediates in the synthesis of inhibitors of tyrosine kinase enzymatic activity
#539Heteroaryl carboxamide compound
#540DIHYDRO-CYCLOPENTA-ISOQUINOLINE SULFONAMIDES DERIVATIVES
#541Methods of inhibiting kinases
#542KINASE INHIBITORS
#543ISOINDOLINONE AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF NUAK KINASES, COMPOSITIONS AND USES THEREOF
#544IMIDAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORS
#545Heterocyclic carboxylate compounds as glycolate oxidase inhibitors
#546MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#547COMPOUNDS AND METHOD FOR PREPARING THE SAME
#548RAD51 BINDING INHIBITORS AND METHODS OF USE THEREOF
#549Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof
#550Near-infrared cyanine dyes and conjugates thereof
#551OXALAMIDE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#552PROTEASE-ACTIVATED CONTRAST AGENTS FOR IN VIVO IMAGING
#553MODIFIED ISOINDOLINONES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
#554HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS
#555Organic electroluminescence device and compound for organic electroluminescence device
#556KETOHEXOKINASE INHIBITOR AND USE THEREOF
#557PYRAZOLE DERIVATIVES USEFUL AS NAMPT MODULATORS
#558Compounds
#559Materials for organic light emitting devices
#560FUSED BICYCLIC PYRAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF HERPESVIRUSES
#561HETEROCYCLIC G-PROTEIN-COUPLED RECEPTOR 52 (GPR52) AGONISTS
#562COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#563TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY
#564PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF
#565SULFONAMIDES WITH EGFR INHIBITION ACTIVITIES AND THEIR USE THEREOF
#566HETEROARYL CARBOXAMIDE COMPOUND
#567PYRIDAZINONES AS PARP7 INHIBITORS
#568MAP KINASE KINASE (MKK7) INHIBITORS AND USES THEREOF
#569TRIAZINE DERIVATIVES AND METHODS OF USE THEREOF
#570Compounds as GCNinhibitors, pharmaceutical compositions and uses thereof
#571Benzamides of pyrazolylamino-pyrimidinyl derivatives, and compositions and methods thereof
#572AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS
#573SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
#574ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE
#575HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME, MANUFACTURING METHOD OF THE SAME AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE
#576Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine
#577COMPOUNDS AS PU. 1 INHIBITORS
#578PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS
#579ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES
#580NOVEL HETEROAROMATIC COMPOUNDS EXHIBITING ANTIFUNGAL ACTIVITY AND THEIR METHOD OF USE
#581HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE
#582NOVEL INDIRUBIN DERIVATIVES HAVING HETEROBICYCLIC MOIETIES AND THE USE THEREOF
#583Azetidinyl Pyrimidines and Uses Thereof
#584PYRROLE-TYPE COMPOUNDS AND USES THEREOF FOR TREATING VIRAL INFECTIONS
#585STING ANTAGONISTS AND USES THEREOF
#586LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING LIGHT-EMITTING DEVICE
#587HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS
#588AMIDE COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF
#589Benzamides of pyrazolylamino-pyrimidinyl derivatives, and compositions and methods thereof
#590(AZA)QUINOLINE 4-AMINES DERIVATIVES AS P2X3 INHIBITORS
#591PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF
#592Uracil Derivatives for Stimulating Read-Through of Premature Termination Codons
#593Azetidine Cyclic Ureas
#594SMALL MOLECULE COMPOUND SERVING AS JAK KINASE INHIBITOR, AND USE THEREOF
#595NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME
#596ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES
#597METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION
#598cGAS INHIBITORS
#599INDOLIN-2-ONE OR PYRROLO -PYRIDIN -2 -ONE DERIVATIVES
#600PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AND RELATED USES